Literature DB >> 8626631

AP-1/jun is required for early Xenopus development and mediates mesoderm induction by fibroblast growth factor but not by activin.

Z Dong1, R H Xu, J Kim, S N Zhan, W Y Ma, N H Colburn, H Kung.   

Abstract

In Xenopus, normal mesoderm formation depends on signaling through the fibroblast growth factor (FGF) tyrosine kinase receptor. An important signaling pathway from receptor tyrosine kinases involves Ras/Raf/MAP kinase. However, the downstream pathway that occurs in the nucleus to finally trigger gene expression for mesoderm formation remains unknown. We report here that a high level of activator protein-1 (AP-1)-dependent transcriptional activity is detected during the early development of Xenopus embryos. Injection of a dominant negative mutant jun (DNM-jun or TAM67) RNA into the two-cell stage embryos inhibited endogenous AP-1 activity and blocked normal embryonic development with severe posterior truncation in tadpoles. The inhibition of AP-1 activity and the phenotypic change induced by TAM67 was rescued by co-injection of wild-type c-jun RNA, but not by the control beta-galactosidase RNA. The FGF-stimulated mesoderm induction was markedly inhibited in animal cap explants from the embryos injected with TAM67. Activin induction of mesoderm, on the other hand, was normal in the embryos injected with TAM67 RNA. These findings suggest that AP-1 mediates FGF, but not activin, receptor signaling during mesoderm induction and the AP-1/Jun is a key signaling molecule in the development of posterior structure.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8626631     DOI: 10.1074/jbc.271.17.9942

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Studies on the role of fibroblast growth factor signaling in neurogenesis using conjugated/aged animal caps and dorsal ectoderm-grafted embryos.

Authors:  R H Xu; J Kim; M Taira; D Sredni; H Kung
Journal:  J Neurosci       Date:  1997-09-15       Impact factor: 6.167

2.  CAPERalpha is a novel Rel-TAD-interacting factor that inhibits lymphocyte transformation by the potent Rel/NF-kappaB oncoprotein v-Rel.

Authors:  Jui Dutta; Gaofeng Fan; Céline Gélinas
Journal:  J Virol       Date:  2008-08-27       Impact factor: 5.103

3.  Cellular activation triggered by the autosomal dominant polycystic kidney disease gene product PKD2.

Authors:  T Arnould; L Sellin; T Benzing; L Tsiokas; H T Cohen; E Kim; G Walz
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

Review 4.  Mechanistic insight into osteoclast differentiation in osteoimmunology.

Authors:  Hiroshi Takayanagi
Journal:  J Mol Med (Berl)       Date:  2005-01-26       Impact factor: 4.599

5.  The AP-1 transcription factor JunB functions in Xenopus tail regeneration by positively regulating cell proliferation.

Authors:  Makoto Nakamura; Hitoshi Yoshida; Eri Takahashi; Marcin Wlizla; Kimiko Takebayashi-Suzuki; Marko E Horb; Atsushi Suzuki
Journal:  Biochem Biophys Res Commun       Date:  2019-12-04       Impact factor: 3.575

6.  The role of heterodimeric AP-1 protein comprised of JunD and c-Fos proteins in hematopoiesis.

Authors:  Sung-Young Lee; Jaeho Yoon; Mee-Hyun Lee; Sung Keun Jung; Dong Joon Kim; Ann M Bode; Jaebong Kim; Zigang Dong
Journal:  J Biol Chem       Date:  2012-07-20       Impact factor: 5.157

7.  Prolactin and estrogen enhance the activity of activating protein 1 in breast cancer cells: role of extracellularly regulated kinase 1/2-mediated signals to c-fos.

Authors:  Jennifer H Gutzman; Sarah E Nikolai; Debra E Rugowski; Jyoti J Watters; Linda A Schuler
Journal:  Mol Endocrinol       Date:  2005-03-03

Review 8.  Biological implications of polydimethylsiloxane-based microfluidic cell culture.

Authors:  Keil J Regehr; Maribella Domenech; Justin T Koepsel; Kristopher C Carver; Stephanie J Ellison-Zelski; William L Murphy; Linda A Schuler; Elaine T Alarid; David J Beebe
Journal:  Lab Chip       Date:  2009-06-04       Impact factor: 6.799

9.  Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation.

Authors:  Fumiyo Ikeda; Riko Nishimura; Takuma Matsubara; Sakae Tanaka; Jun-ichiro Inoue; Sakamuri V Reddy; Kenji Hata; Kenji Yamashita; Toru Hiraga; Toshiyuki Watanabe; Toshio Kukita; Katsuji Yoshioka; Anjana Rao; Toshiyuki Yoneda
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

10.  Multiple kinase cascades mediate prolactin signals to activating protein-1 in breast cancer cells.

Authors:  Jennifer H Gutzman; Debra E Rugowski; Matthew D Schroeder; Jyoti J Watters; Linda A Schuler
Journal:  Mol Endocrinol       Date:  2004-08-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.